Answers are grounded in this paper and cite their sources.
Demonstrates anti-metastatic potential of targeting fatty acid metabolism in tumors, suggesting new therapeutic options.
Fatty acid metabolism is a core metabolic pathway regulating tumor metastasis. Through fatty acid uptake and intracellular transport mediated by CD36 and fatty acid-binding proteins (FABPs), fatty acid oxidation (FAO) regulated by carnitine palmitoyltransferase 1 (CPT1), and fatty acid desaturation modification mediated by stearoyl-CoA desaturase 1 (SCD1) and fatty acid desaturase 2 (FADS2), it modulates the entire process of tumor cell invasion, circulatory survival and distal colonization from the perspectives of membrane lipid remodeling, energy homeostasis and signal transduction. The metabolic heterogeneity of cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT)-like cells, as well as the metabolic reprogramming mediated by the target organ microenvironment, further enhance metastatic plasticity and organotropism. Interventional strategies targeting key molecules of fatty acid metabolism have shown promising anti-metastatic potential, providing a core research direction for subsequent precise metabolic targeted therapy against metastasis.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: